Metropolitan Life Insurance Company (MetLife)’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-48,391
Closed -$61.5K 2765
2021
Q4
$61.5K Buy
48,391
+6,863
+17% +$12.3K ﹤0.01% 2675
2021
Q3
$90.5K Buy
41,528
+10,951
+36% +$29.9K ﹤0.01% 2582
2021
Q2
$115K Sell
30,577
-7,878
-20% -$27.4K ﹤0.01% 2526
2021
Q1
$125K Sell
38,455
-3,937
-9% -$14.1K ﹤0.01% 2322
2020
Q4
$145K Sell
42,392
-353
-0.8% -$1.45K ﹤0.01% 2155
2020
Q3
$174K Buy
42,745
+4,776
+13% +$18.2K ﹤0.01% 1856
2020
Q2
$128K Sell
37,969
-162
-0.4% -$472 ﹤0.01% 2105
2020
Q1
$88.8K Buy
38,131
+2,219
+6% +$6.07K ﹤0.01% 2102
2019
Q4
$131K Sell
35,912
-1,661
-4% -$13.4K ﹤0.01% 2173
2019
Q3
$312K Buy
37,573
+4,099
+12% +$33.2K 0.01% 1591
2019
Q2
$288K Buy
33,474
+1,105
+3% +$9.88K ﹤0.01% 1644
2019
Q1
$346K Hold
32,369
0.01% 1537
2018
Q4
$283K Hold
32,369
0.01% 1580
2018
Q3
$544K Hold
32,369
0.01% 1299
2018
Q2
$678K Buy
32,369
+4,181
+15% +$77.5K 0.01% 1116
2018
Q1
$454K Buy
28,188
+676
+2% +$13.4K 0.01% 1347
2017
Q4
$521K Sell
27,512
-30,888
-53% -$560K 0.01% 1263
2017
Q3
$822K Sell
58,400
-431
-0.7% -$3.9K 0.01% 1367
2017
Q2
$438K Hold
58,831
﹤0.01% 1796
2017
Q1
$382K Buy
58,831
+5,111
+10% +$28.6K ﹤0.01% 1844
2016
Q4
$238K Sell
53,720
-5,567
-9% -$23.4K ﹤0.01% 2243
2016
Q3
$277K Buy
59,287
+8,929
+18% +$52.9K ﹤0.01% 2119
2016
Q2
$331K Buy
50,358
+3,803
+8% +$26.9K ﹤0.01% 1957
2016
Q1
$296K Hold
46,555
﹤0.01% 1905
2015
Q4
$281K Hold
46,555
﹤0.01% 2014
2015
Q3
$278K Buy
46,555
+1,787
+4% +$12.4K ﹤0.01% 2028
2015
Q2
$306K Sell
44,768
-4,322
-9% -$27.4K ﹤0.01% 2104
2015
Q1
$298K Sell
49,090
-45
-0.1% -$299 ﹤0.01% 1849
2014
Q4
$341K Hold
49,135
﹤0.01% 2039
2014
Q3
$400K Hold
49,135
﹤0.01% 1860
2014
Q2
$399K Hold
49,135
﹤0.01% 2000
2014
Q1
$385K Hold
49,135
﹤0.01% 1987
2013
Q4
$435K Hold
49,135
﹤0.01% 1902
2013
Q3
$412K Hold
49,135
﹤0.01% 1889
2013
Q2
$367K Buy
+49,135
New +$377K ﹤0.01% 1911

Other funds holding SPPI

Metropolitan Life Insurance Company (MetLife)'s SPPI Position: Q1 2022 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q1 2022, closing a stake of 48,391 shares — an estimated $61.5K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in SPPI in Q2 2013 and held it in 35 quarters. The position peaked at $822K in Q3 2017. 101 funds tracked by Wall St. Rank hold SPPI as of Q1 2022.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Spectrum Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 48,391 Spectrum Pharmaceuticals Inc shares in Q1 2022, an estimated $61.5K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Spectrum Pharmaceuticals Inc in Q2 2013 and held it in 35 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Spectrum Pharmaceuticals Inc position peaked at $822K in Q3 2017.
  • 101 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q1 2022.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q1 2022, filed 12 May 2022.